Related references
Note: Only part of the references are listed.Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type
Yenlin Huang et al.
BLOOD (2010)
The NF-κB negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas
Urban Novak et al.
BLOOD (2009)
TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas
Keiichiro Honma et al.
BLOOD (2009)
Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia
Yasuo Yamanaka et al.
BLOOD (2009)
A New Fork for Clinical Application: Targeting Forkhead Transcription Factors in Cancer
Jer-Yen Yang et al.
CLINICAL CANCER RESEARCH (2009)
Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies
J. Iqbal et al.
LEUKEMIA (2009)
STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma
P. Coppo et al.
LEUKEMIA (2009)
Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
Mara Compagno et al.
NATURE (2009)
Frequent inactivation of A20 in B-cell lymphomas
Motohiro Kato et al.
NATURE (2009)
IRF4 addiction in multiple myeloma
Arthur L. Shaffer et al.
NATURE (2008)
Oncogenic CARD11 mutations in human diffuse large B cell lymphoma
Georg Lenz et al.
SCIENCE (2008)
Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis
Yiyu Zou et al.
BREAST CANCER RESEARCH (2008)
The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers
Liyong Zhang et al.
NATURE MEDICINE (2007)
Genome-wide array-based comparative genomic hybridization of ocular marginal zone B cell lymphoma: Comparison with pulmonary and nodal marginal zone B cell lymphoma
Won Seog Kim et al.
GENES CHROMOSOMES & CANCER (2007)
FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis
Ji-Hye Paik et al.
CELL (2007)
Aberrant NF-kappa B signaling in lymphoma: mechanisms, consequences, and therapeutic implications
Philipp J. Jost et al.
BLOOD (2007)
Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas
W Tam et al.
BLOOD (2006)
A loss-of-function RNA interference screen for molecular targets in cancer
VN Ngo et al.
NATURE (2006)
Efficient calculation of interval scores for DNA copy number data analysis
D Lipson et al.
JOURNAL OF COMPUTATIONAL BIOLOGY (2006)
Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma
L Pasqualucci et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: Different genomic alteration patterns of aggressive NK-cell leukemia and extranodal NK/T-cell lymphoma, nasal type
Y Nakashima et al.
GENES CHROMOSOMES & CANCER (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma
H Tagawa et al.
BLOOD (2005)
Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney
MS Anglesio et al.
HUMAN MOLECULAR GENETICS (2004)
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling
IE Wertz et al.
NATURE (2004)
The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses
DL Boone et al.
NATURE IMMUNOLOGY (2004)
Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma
A Ota et al.
CANCER RESEARCH (2004)
Stability and subcellular localization of API2-MALT1 chimeric protein involved in t(11;18) (q21;q21) MALT lymphoma
K Izumiyama et al.
ONCOGENE (2003)
Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions
Y Zhang et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Common mechanism for oncogenic activation of MLL by forkhead family proteins
CW So et al.
BLOOD (2003)
Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936
JJM van Dongen et al.
LEUKEMIA (2003)
Characterization of novel natural killer (NK)-cell and γδ T-cell lines established from primary lesions of nasal T/NK-cell lymphomas associated with the Epstein-Barr virus
H Nagata et al.
BLOOD (2001)
Consistent patterns of allelic loss in natural killer cell lymphoma
LLP Siu et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation
M Yagita et al.
LEUKEMIA (2000)
Share Paper
